Biodegradable Amphipathic Peptide Hydrogels as Extended-Release System for Opioid Peptides

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Pain Management Research

Background:

• Chronic pain management often relies on opioids, which have limited long-term efficacy and significant side effects.
• A critical need exists for alternative, safer, and more effective pain therapies.
• Peptide-based hydrogels present a promising platform for advanced drug delivery applications.

Purpose of the Study:

• To develop and evaluate peptide-based hydrogels as extended-release carriers for pain management.
• To investigate two distinct formulation strategies for drug incorporation into hydrogels.
• To assess the prolonged antinociceptive effects of these hydrogel formulations in a preclinical model.

Main Methods:

• Synthesis and characterization of peptide-based hydrogels.
• Development of two drug-eluting hydrogel formulations: coformulation and integral part.
• Subcutaneous administration of hydrogels in a mouse model of pain.
• Evaluation of antinociception duration and efficacy up to 72 hours post-administration.

Main Results:

• Both peptide-hydrogel formulations demonstrated prolonged and significant antinociception.
• Sustained pain relief was observed for up to 72 hours following a single subcutaneous administration.
• The developed hydrogels effectively served as extended-release drug delivery carriers.

Conclusions:

• Peptide-based hydrogels are effective extended-release carriers for managing chronic pain.
• These novel formulations offer a promising alternative to current opioid-based pain therapies.
• The developed hydrogel strategies provide sustained antinociception, potentially improving patient outcomes.